Amanda Louise Murphy - 29 Jul 2021 Form 3 Insider Report for MAXCYTE, INC. (MXCT)

Role
Chief Financial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MXCT
Transactions as of
29 Jul 2021
Transactions value $
$0
Form type
3
Date filed
29 Jul 2021, 18:43
Next filing
11 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MXCT Employee Stock Option (right to buy) 29 Jul 2021 Common Stock 1.15M $4.54 Direct F1, F2
holding MXCT Employee Stock Option (right to buy) 29 Jul 2021 Common Stock 55.5K $14.30 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth (1/16th) of the shares underlying this option vested on December 7, 2020, and the remainder vested or shall vest monthly in forty-five (45) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.3749 as of July 23, 2021.
F3 Twenty-five percent (25%) of the shares underlying this option shall vest on January 13, 2022, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney